Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2008 5
2009 2
2010 1
2011 1
2012 3
2013 1
2019 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies.
Kurdi M, Butt NS, Baeesa S, Alghamdi B, Maghrabi Y, Bardeesi A, Saeedi R, Dallol A, Mohamed F, Bari MO, Samkari A, Lary AI, Alkhayyat S. Kurdi M, et al. Among authors: bari mo. J Neurooncol. 2021 May;152(3):541-549. doi: 10.1007/s11060-021-03723-9. Epub 2021 Mar 4. J Neurooncol. 2021. PMID: 33661424 Free PMC article.
Extrapyramidal side-effects of antipsychotics in a randomised trial.
Miller DD, Caroff SN, Davis SM, Rosenheck RA, McEvoy JP, Saltz BL, Riggio S, Chakos MH, Swartz MS, Keefe RS, Stroup TS, Lieberman JA; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Miller DD, et al. Br J Psychiatry. 2008 Oct;193(4):279-88. doi: 10.1192/bjp.bp.108.050088. Br J Psychiatry. 2008. PMID: 18827289 Free PMC article. Clinical Trial.
The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents.
Kurdi M, Shafique Butt N, Baeesa S, Alghamdi B, Maghrabi Y, Bardeesi A, Saeedi R, Al-Sinani T, Alghanmi N, Bari MO, Samkari A, Lary AI. Kurdi M, et al. Among authors: bari mo. Pathol Oncol Res. 2021 Apr 29;27:1609778. doi: 10.3389/pore.2021.1609778. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257620 Free PMC article.
A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder.
Papakostas GI, Vitolo OV, Ishak WW, Rapaport MH, Zajecka JM, Kinrys G, Mischoulon D, Lipkin SH, Hails KA, Abrams J, Ward SG, Meisner A, Schoenfeld DA, Shelton RC, Winokur A, Okasha MS, Bari MA, Fava M. Papakostas GI, et al. Among authors: bari ma. J Clin Psychiatry. 2012 Dec;73(12):1541-7. doi: 10.4088/JCP.12m07670. J Clin Psychiatry. 2012. PMID: 23290327 Clinical Trial.
18 results